With 0.5 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.5 million shares. The 52-week range on PACS shows that it touched its highest point at $43.92 and its lowest point at $8.28 during that stretch. It currently has a 1-year price target of $28.00. Beta for the stock currently stands at 0.21.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PACS was up-trending over the past week, with a rise of 4.33%, but this was up by 5.07% over a month. Three-month performance dropped to -20.73% while six-month performance fell -34.84%. The stock lost -66.00% in the past year, while it has lost -20.98% so far this year. For the next quarter, that number is 0.44. This implies an EPS growth rate of 11.63% for this year and 14.65% for next year.
Float and Shares Shorts:
At present, 152.40 million PACS shares are outstanding with a float of 39.11 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PACS since 5 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.49745 being high and $1.45383 being low. For PACS, this leads to a yearly average estimate of $1.48291.
